Su, CP, HJ Chai, YS See, and R Sures Kumar. “GLYCEMIC CONTROL AND BODY WEIGHT EFFECTS OF SGLT2 INHIBITORS (EMPAGLIFLOZIN 25 MG, EMPAGLIFLOZIN 12.5 MG AND DAPAGLIFLOZIN 10 MG) IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS: A SINGLE CENTRE STUDY”. Journal of the ASEAN Federation of Endocrine Societies 39, no. S1 (July 17, 2024): 25. Accessed July 20, 2024. https://asean-endocrinejournal.org/index.php/JAFES/article/view/4457.